Focused fundamental and scientific investment process
A deep focus on scientific and financial research is essential to our understanding of how regulatory and innovation dynamics influence and affect the marketplace. We invest mostly in publicly-listed therapeutic companies, ranging from early-stage small capitalization biotechnology companies to multinational large capitalization pharmaceutical conglomerates. Our investment specialists aim to capitalize on significant scientific, technological and policy changes. Collectively, we utilize a fundamental research approach anchored in science and financial analysis to identify high-conviction investment opportunities.